Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study has been designed as a 12-month, open-label randomized controlled clinical trial.
The study aims to compare the efficacy and safety of two treatment strategies in active
IgG4-RD patients with internal organ involvement during maintenance remission period: low
dose mycophenolate mofetil group and leflunomide group.